ACME UNITED CORP - 10-K Summary (Fiscal Year Ended Dec 31, 2024)
Business Context and Reporting Period
Company: ACME UNITED CORP (ACU)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: A leading worldwide supplier of first aid, medical products, and cutting/sharpening tools. Operations are segmented geographically into the United States (including Asia), Canada, and Europe. The company sells primarily to mass market retailers, e-commerce platforms, and industrial distributors.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Net Sales | $194.5 million | $191.5 million |
| Gross Profit | $76.4 million (39.3% margin) | $72.2 million (37.7% margin) |
| Operating Income | $14.1 million | $13.2 million |
| Net Income | $10.0 million | $17.8 million |
| Diluted EPS | $2.45 | $4.86 |
| Operating Cash Flow | $12.0 million | $28.9 million |
| Total Debt Outstanding | $28.0 million | $23.4 million |
| Credit Facility Availability | $47.4 million | $51.9 million |
| Cash & Equivalents | $6.4 million | $4.8 million |
Note: 2023 Net Income included a one-time gain of $12.6 million from the sale of the Camillus and Cuda business lines.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2% year-over-year. Excluding the impact of the divested hunting/fishing lines, organic sales grew 6%.
- Profitability: Gross margin expanded to 39.3% from 37.7% due to productivity improvements. However, Net Income declined significantly due to the absence of the $12.6 million gain on sale of business recorded in 2023.
- Acquisitions: Acquired Elite First Aid, Inc. in May 2024 for approximately $7.1 million to expand tactical and trauma product lines.
- Divestitures: Completed the sale of Camillus and Cuda business lines in late 2023; received final holdback payment in November 2024.
- Cost Structure: SG&A expenses increased 5.4% primarily due to higher personnel costs, though cost reduction initiatives yielded approximately $2 million in annual savings.
Guidance, Outlook, and Risks
Management Commentary: Management highlights a strong financial position with $47 million in credit availability to fund growth and acquisitions. The company increased its quarterly dividend to $0.15 per share. Cost reduction and productivity enhancements are ongoing.
Key Risks and Contingencies:
- Internal Control Material Weakness: The company identified a material weakness in Information Technology General Controls (ITGCs) related to logical security and privileged access management. This resulted in an adverse opinion from auditors on internal controls, though the financial statements received an unqualified opinion.
- Trade and Tariffs: Significant exposure to U.S.-China trade tensions and new tariffs imposed in early 2025 on Chinese, Canadian, and Mexican goods, which could increase costs and disrupt supply chains.
- Customer Concentration: Two customers accounted for approximately 27% of total net sales in 2024.
- Geopolitical Instability: Ongoing conflicts in Ukraine and the Middle East pose risks to supply chains and freight costs.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of remediation efforts for the ITGC material weakness and the implementation of the new Privileged Access Management (PAM) solution expected in Q1 2025.
- Tariff Impact: Assess the specific financial impact of new tariffs imposed in February 2025 on the company's Asian supply chain and pricing power.
- Acquisition Integration: Monitor the performance and integration of the Elite First Aid acquisition to ensure expected synergies are realized.
- Customer Concentration: Review the stability of relationships with the two major customers representing 27% of revenue.
- Debt Covenants: Confirm continued compliance with debt covenants, specifically the funded debt to EBITDA ratio and fixed charge coverage ratio.